Gotowa bibliografia na temat „Nicotine patches”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Nicotine patches”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Nicotine patches"
&NA;. "Nicotine patches". Inpharma Weekly &NA;, nr 1197 (lipiec 1999): 7. http://dx.doi.org/10.2165/00128413-199911970-00012.
Pełny tekst źródłaBenowitz, N. L. "Nicotine patches". BMJ 310, nr 6991 (27.05.1995): 1409–10. http://dx.doi.org/10.1136/bmj.310.6991.1409b.
Pełny tekst źródłaKalra, Roma, Shashi P. Singh, Juan C. Pena-Philippides, Raymond J. Langley, Seddigheh Razani-Boroujerdi i Mohan L. Sopori. "Immunosuppressive and Anti-Inflammatory Effects of Nicotine Administered by Patch in an Animal Model". Clinical Diagnostic Laboratory Immunology 11, nr 3 (maj 2004): 563–68. http://dx.doi.org/10.1128/cdli.11.3.563-568.2004.
Pełny tekst źródłaMiller, Virginia M., W. Darrin Clouse, Britt H. Tonnessen, Umar S. Boston, Sandra R. Severson, Sue Bonde, Kevin S. Rud i Richard D. Hurt. "Time and dose effect of transdermal nicotine on endothelial function". American Journal of Physiology-Heart and Circulatory Physiology 279, nr 4 (1.10.2000): H1913—H1921. http://dx.doi.org/10.1152/ajpheart.2000.279.4.h1913.
Pełny tekst źródłaWalker, Natalie, Marjolein Verbiest, Tomasz Kurdziel, George Laking, Murray Laugesen, Varsha Parag i Chris Bullen. "Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial". BMJ Open 9, nr 2 (luty 2019): e023659. http://dx.doi.org/10.1136/bmjopen-2018-023659.
Pełny tekst źródłaUeda, Kimiko. "Nicotine patches in Japan". Lancet 358, nr 9280 (sierpień 2001): 512. http://dx.doi.org/10.1016/s0140-6736(01)05660-4.
Pełny tekst źródłaPalmer, R., C. Scully i D. H. Felix. "Nicotine, smoke and patches". British Dental Journal 200, nr 2 (styczeń 2006): 65. http://dx.doi.org/10.1038/sj.bdj.4813187.
Pełny tekst źródłaJarvis, M. J., M. A. Russell i C. Feyerabend. "Unlicensed nicotine skin patches." BMJ 306, nr 6878 (6.03.1993): 647. http://dx.doi.org/10.1136/bmj.306.6878.647.
Pełny tekst źródłaRuela, André Luís Morais, Eduardo Costa Figueiredo, Aline Gravinez Perissinato, Ana Carolina Zogbi Lima, Magali Benjamim Araújo i Gislaine Ribeiro Pereira. "In vitro evaluation of transdermal nicotine delivery systems commercially available in Brazil". Brazilian Journal of Pharmaceutical Sciences 49, nr 3 (wrzesień 2013): 579–88. http://dx.doi.org/10.1590/s1984-82502013000300020.
Pełny tekst źródłaKang, Jeong Ho, i Sung Kgun Lee. "Progressive nicotine poisoning by multiple transdermal nicotine patches". Journal of Medicine and Life Science 18, nr 2 (31.08.2021): 31–34. http://dx.doi.org/10.22730/jmls.2021.18.2.31.
Pełny tekst źródłaRozprawy doktorskie na temat "Nicotine patches"
Foulds, Jonathan Andrew. "An investigation into the role of nicotine in tobacco smoking and smoking cessation". Thesis, King's College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264960.
Pełny tekst źródłaSonmez, Nurhak. "Effectiveness Of A Smoking Cessation Program Combined With Transdermal Nicotine". Master's thesis, METU, 2008. http://etd.lib.metu.edu.tr/upload/12609428/index.pdf.
Pełny tekst źródłaMyers, K. "Effects of a combination of a varenicline and transdermal nicotine patch on post-quitting urges to smoke". Thesis, City, University of London, 2012. http://openaccess.city.ac.uk/19982/.
Pełny tekst źródłaJayakar, Selwyn S. "Abl family kinases regulate neuronal nicotinic receptors and synapses in chick ciliary ganglion neurons". Connect to full text in OhioLINK ETD Center, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=mco1242668863.
Pełny tekst źródła"In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences." Title from title page of PDF document. Bibliography: p. 138-150.
Steinhafel, Nathan W. "Expression and Function of Alpha3 and Beta2 Neuronal Nicotinic Acetylcholine Receptor Subunits in HEK-293 Cells". Diss., CLICK HERE for online access, 2006. http://contentdm.lib.byu.edu/ETD/image/etd1665.pdf.
Pełny tekst źródłaBiet, Michaël. "Rôle et implication du courant sodique cardiaque dans la genèse de phénomènes arythmogéniques en conditions physiopathologiques". Thèse, Université de Sherbrooke, 2015. http://hdl.handle.net/11143/6054.
Pełny tekst źródłaSutter, Jens-Uwe. "Charakterisierung regulatorischer Schritte in der konstitutiven Exocytose in Pflanzenzellen". Doctoral thesis, [S.l.] : [s.n.], 2000. http://deposit.ddb.de/cgi-bin/dokserv?idn=963101315.
Pełny tekst źródłaHotham, Elizabeth. "Use of nicotine patches by pregnant women : assessment of acceptability and safety". 2000. http://arrow.unisa.edu.au:8081/1959.8/46677.
Pełny tekst źródłaLai, Chih-Kuan, i 賴志冠. "Comparative effectiveness of varenicline and nicotine patch reimbursed partially in health service". Thesis, 2010. http://ndltd.ncl.edu.tw/handle/58891010856261162771.
Pełny tekst źródła臺灣大學
流行病學研究所
98
Background: National Smoking Cessation Service (NSCS), implemented since 2002, encourages and promotes motivated smokers to participate anti-smoking treatment by partially reimbursing related pharmacotherapy. Varenicline is a novel, recently launched adjuvant for treating tobacco dependence. Its long term cessation rate is superior to traditional treatment in randomized controlled trials (RCTs). However, whether its efficacy can be translated into daily practice with a partial coverage of drug expense remains unclear. Aim: The aim of this study is three folds: (1) To investigate the comparative effectiveness of varenicline and nicotine patch in a health care system with partial coverage; (2) To determine whether varenicline still maintain a better effectiveness than nicotine patch as it does in RCTs; (3) To identify any possible factors that influence or lead to the difference of the treatment outcome between varenicline and nicotine patch? Material and method: Eligible participants are: (1) aged 20 to 70 years; (2) those who received varenicline or nicotine patch (Nicotinell) between Apr 2006 and Nov 2009 in NSCS; and (3) qualified for the telephone follow-up made 6 months after their first visit of smoking cessation service. We recruited 1,117 participants in varenicline group and 1,211 in nicotine patch group. The primary outcome of analysis is 7-day point prevalent abstinence (PPA) at 6months. The secondary outcome is the duration of prescribed pharmacotherapy (in weeks). Statistic analysis: Logistic regression is used for association analysis to find the related factors. Result: The success of cessation at 6 months after initiating treatment is mainly determined by the type of pharmacotherapy and its duration of prescription in our study. The ORs are 1.48 (95% CI: 1.20–1.81) for varenicline group vs. Nicotinell patch group and 2.18 (95% CI: 1.72–2.75) for those with at least 4 weeks of prescribed pharmacotherapy vs. those less than 4 weeks. Older age is a modest but positive factor to enhance successful cessation. There are two negative factors to curb cessation attempt: smoker in the household (OR=0.71, 95% CI: 0.56–0.88) and higher FTND (Fagerstrom Tolerance of Nicotine Dependence) score (OR=0.87, 95% CI: 0.83–0.91). The durations of prescription are only 3.16±2.25 weeks and 2.39±1.97 weeks in varenicline and Nicotinell group respectively. Both are far below than guideline recommendation. Discussion and Suggestion: Varenicline is more effective in treating tobacco use as compared with Nicotinell patch no matter the duration of prescription is at least or less than 4 weeks in routine daily practice. The findings of this comparative effectiveness research are similar to those identified in previous RCTs. In addition, the participants who receive varenicline also tend to be more compliant than those treated with Nicotinell patch. The better compliance of varenicline will synergistically exaggerate its treatment effect. Under-treatment is a common problem in NSCS. Most participants terminate adjuvant therapy prematurely. Varenicline with partial coverage is relatively expensive and infrequently prescribed in NSCS. A new strategy to encourage the distribution and prescription of varenicline is imperative to improve the cessation rate of NSCS.
Sie, Cheng-Kai, i 謝承凱. "Effects of acute dose nicotine patch on force of muscle, explosive power and reaction time". Thesis, 2013. http://ndltd.ncl.edu.tw/handle/03707886063786206513.
Pełny tekst źródła國立體育大學
運動科學研究所
101
The purpose of this study was to investigate whether the acute dose of nicotine patch could alter the catecholamine secretion and thereby affecting the muscle force, explosive power and reaction time among college male students. The subjects were nine male students (22.2 ± 1.4 years) from the National Taiwan Sports University. Participants received the treatments of nicotine group (NIC) and placebo (PLB) test followed by crossing over experimental design. Both groups were examined the muscle force, explosive power and reaction time of the indicated exercise. Paired T-test stat was used to analyze the differences between those two groups. There was no statistically significance difference in terms of urine catecholamines between those two groups. However, muscle force, explosive power and reaction time were all significantly differences (P <.05) from each other . The results showed that acute dose of nicotine patch could possibly enhance not only the subjects' muscle force and explosive power, but also prolonging the reaction time.
Książki na temat "Nicotine patches"
Quit Smart: Stop smoking : With the Nicotine Skin Patch and other new methods. JB Press, 1994.
Znajdź pełny tekst źródłaCzęści książek na temat "Nicotine patches"
Jones, T. E. "Smoking cessation programme with nicotine patches for employees of a teaching hospital". W Tobacco: The Growing Epidemic, 711–13. London: Springer London, 2000. http://dx.doi.org/10.1007/978-1-4471-0769-9_305.
Pełny tekst źródłaTiro, Jasmin, Simon J. Craddock Lee, Steven E. Lipshultz, Tracie L. Miller, James D. Wilkinson, Miriam A. Mestre, Barbara Resnick i in. "Nicotine Patch". W Encyclopedia of Behavioral Medicine, 1336–37. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_269.
Pełny tekst źródłaRose, Jed E. "Nicotine Patch". W Encyclopedia of Behavioral Medicine, 1504–5. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_269.
Pełny tekst źródłaGonzàlez Quintana, J., D. Marín Tuyà, M. J. Consuegra Manzanares i A. Garcia Baena. "Improving the effectiveness of the transdermal Nicotine Patch: A multicentre study". W Tobacco: The Growing Epidemic, 708–9. London: Springer London, 2000. http://dx.doi.org/10.1007/978-1-4471-0769-9_303.
Pełny tekst źródłaParks, Randolph W., Carter S. Young, Robert F. Rippey, Valerie Danz, Cathy Vohs, Jane R. Matthews, G. Todd Collins i in. "Nicotinic Stimulation of Anterior Regional Cerebral Glucose Metabolism in Alzheimer’s Disease: Preliminary Study with Transdermal Patches". W Alzheimer Disease, 424–27. Boston, MA: Birkhäuser Boston, 1994. http://dx.doi.org/10.1007/978-1-4615-8149-9_70.
Pełny tekst źródłaRichmond, Robyn, Abilio Almeida Neto, Kathy Harris i Colin Mendelsohn. "Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy". W Tobacco and Health, 817–20. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1907-2_184.
Pełny tekst źródłaShuy, Roger W. "Nicotine Patch Advertisements". W Fighting over Words, 55–62. Oxford University Press, 2008. http://dx.doi.org/10.1093/acprof:oso/9780195328837.003.0007.
Pełny tekst źródłaSeutin, Vincent, Bernard Dor i Éric Englebert. "Chapitre 15. Les gommes et les patchs de nicotine sont-ils vraiment utiles au sevrage ?" W Le tabac en questions, 133–40. Mardaga, 2020. http://dx.doi.org/10.3917/mard.seuti.2020.02.0133.
Pełny tekst źródłaStreszczenia konferencji na temat "Nicotine patches"
Wirapatrungrot, Supawat, i Phakkharawat Sittiprapaporn. "Alteration of human brainwaves to the single dose of nicotine patch". W 2017 International Conference on Digital Arts, Media and Technology (ICDAMT). IEEE, 2017. http://dx.doi.org/10.1109/icdamt.2017.7904992.
Pełny tekst źródłaRaporty organizacyjne na temat "Nicotine patches"
Using both nicotine patches and gum together improves the chances of quitting smoking. National Institute for Health Research, lipiec 2019. http://dx.doi.org/10.3310/signal-000786.
Pełny tekst źródła